Published in Obesity and Diabetes Week, May 15th, 2006
The initial order, of 5000 units, will reach market shortly, said Imagenetix. Beijing Yinsheng Pharmaceutics (BYP), a major distributor of health-related goods in China, will distribute the product.
Pending approval from the Ministry of Health, which is expected imminently, Lepitrim will commence general sale throughout China.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.